This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Aortic Endografts Market - 12% Growth During 2012

DUBLIN, March 7, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/bxcq5h/aortic_endografts) has announced the addition of the "Aortic Endografts Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global aortic stent grafts market grew by 12% during 2012 and closed the year touching $1.8 billion in revenue. New generation of lower profile devices were rolled out during the year which further expanded the universe of patients eligible for endovascular repair and the overall market.

According to thought leaders, the years ahead promise to be even more exciting. Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta and before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.

Aortic Endografts Market attempts to answer some important questions regarding the fast evolving aortic endografts landscape. The report analyzes revenue and growth trends for the entire market with special emphasis on abdominal, thoracic and fenestrated stent graft segments.

Aortic Endografts Market is targeted at senior executives in the medical device industry who wish to get up-to-date with this two billion dollar fast growing market. Key Topics Covered: 1. Executive Summary 2. Aortic Aneurysms 3. Global Aortic Stent Grafts Market 4. Anatomical Segmentation of Aortic Endografts Market 5. Geographical Segmentation of Aortic Endografts Market 6. Aortic Endografts Market Forecast List of Tables & Figures: Companies Mentioned - Altura - Aptus Endosystems - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Lifetech Scientific - Gore Medical - Johnson & Johnson - Jotec - Lombard Medical - Medtronic - Microport Medical - Nano Endoluminal - Terumo - TriVascular For more information visit http://www.researchandmarkets.com/research/bxcq5h/aortic_endografts

Research and Markets Laura Wood, Senior Manager. press@researchandmarkets.com U.S. Fax: +1-646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices, Medical Devices, Cardiovascular Devices

SOURCE Research and Markets

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,412.64 -266.06 -1.50%
S&P 500 2,033.34 -23.75 -1.15%
NASDAQ 4,698.2630 -73.50 -1.54%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs